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Current models of the germinal center (GC) response
propose that after stimulation at the edges of T cell
zones, pre-GC B cells directly migrate to the center
of follicles and proliferate to form GCs. We followed
the interrelationship of proliferation, differentiation,
and microenvironmental locale in populations of
pre-GC B cells responding to antigen. In contrast to
the predictions of currentmodels, after accumulation
at the T-B interface, these cells appeared at the
perimeter of follicles adjacent to the marginal zone.
There, they rapidly proliferated for several days but
underwent no V gene hypermutation and little
heavy-chain class switching. Their chemokine
receptor expression pattern indicated that these
cells were sessile, yet they had begun to acquire
many phenotypic characteristics of GC B cells. The
expanded clones were subsequently observed in
the center of follicles, suggesting that GCs are
created by coalescence of B cells from this follicular
perimeter response.
INTRODUCTION
During T cell dependent (TD) immune responses, B cells undergo
proliferation, differentiation, and selection in the microenviron-
ment of the germinal center (GC), thereby leading to the forma-
tion of the memory B cell compartment. According to many
models, the GC response takes place in a series of discrete
stages (Kelsoe and Zheng, 1993; MacLennan, 1994; Liu and
Arpin, 1997; Camacho et al., 1998). After their antigen receptors
(BCRs) engage antigen, follicular B cells migrate to near the
border of T zones and undergo cognate interaction with helper
T cells. Subsequently, pre-GC B cells travel to the center of the
follicle and rapidly proliferate in association with follicular
dendritic cells (FDCs), resulting in formation of the GC proper.
It has been suggested that during this early phase of clonal
expansion, changes in the structure and function of BCRs do
not occur, and this results in the generation of a sufficient pool
of precursors to sustain the somatic-hypermutation-selection
and differentiation processes that ensue (Jacob et al., 1991).Histologic and flow cytometric GC ‘‘time course’’ studies have
provided support for this idea (Berek et al., 1991; Jacob et al.,
1991; Jacob and Kelsoe, 1992; McHeyzer-Williams et al.,
1993; Camacho et al., 1998; Vora et al., 1999), but their limited
resolution has not allowed a distinction between initial B cell
clonal expansion in and recruitment to the GC. Moreover, recent
multiphoton imaging studies of ongoing GC reactions in lymph
nodes have revealed a far greater degree of plasticity of GC B
cell behavior than predicted by previous models of this response
(Allen et al., 2007; Schwickert et al., 2007; Hauser et al., 2007). In
particular, these analyses demonstrated extensive migration of
individual GC B cells within, around, into, and out of the GC
proper.
Given the above considerations, we performed a detailed
analysis of the interrelationship of proliferation, differentiation,
and microenvironmental locale in homogenous populations of
pre-GC B cells during the early stages of TD immune responses.
These studies revealed a previously unappreciated stage of the
GC B cell developmental pathway, in which pre-GC B cells
undergo rapid clonal expansion at the perimeter of follicles
without induction of somatic hypermutation, heavy-chain class
switching, or expression of genes necessary for homing to the
center of follicles. Our findings necessitate revision of previous
models for the GC response.
RESULTS
VH Gene-Targeted Transgenic Mice
We utilized a previously described line of Igh locus VH gene-
targeted transgenic mice termed HKI65 for our studies (Hel-
temes-Harris et al., 2004). B cells in these mice express a high
frequency of BCRs that bind the hapten arsonate (Ars) and are
encoded by a single V gene segment combination and thus are
termed ‘‘canonical.’’ Such targeted VH loci efficiently undergo
somatic hypermutation (SHM) and class switch recombination
(CSR) (Taki et al., 1995; Shih et al., 2002). For most experiments,
HKI65 Igh+/ mice were mated to a previously described line of
immunoglobulin (Ig) light (L) chain transgenic mice expressing
the canonical Vk10A-Jk1 L chain gene (Liu et al., 2007), creating
double-transgenic mice we term HKI65-Vk10. Greater than 95%
of B cells in these mice express canonical BCRs that are readily
detected in histological and flowcytometric analyseswith the an-
ticlonotypic mAbs E4 (Notidis et al., 2002; Heltemes-Harris et al.,
2004) or 5Ci (Wysocki and Sato, 1981; B.A., unpublished data).
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Figure 1. Microenvironmental Locale of HKI65-Vk10 Donor B Cells
during the First Five Days of the Immune Response in Ars-KLH
Preimmunized Mice
Recipient mice were primed with 100 mg of Ars-KLH in alum i.p. and injected
with HKI65-Vk10 B cells 1 week later; this was followed by a single injection
of Ars-KLH in PBS as described in Experimental Procedures. Mice were sacri-
ficed at different time points and spleen sections were analyzed.
(A) Day 1, left panel illustrates the localization of CFSE-labeled donor B cells
(107 injected per recipient mouse), which appear green, on the first day after
transfer. Day 1, right panel shows donor B cells (107 injected per recipient
mouse) expressing the CD45.2 allotypicmarker (red) concentrated at the inter-
face of B (green) and T (unstained) cell zones. The remaining panels illustrate
the location of CD45.2+ donor B cells (red, 2 3 104 injected per recipient
mouse) at days 2–4 after immunization (adjacent sections next to each other).
We usedMOMA1 staining (blue) to identify metallophiles in theMZ, delineating
the follicular border. T cells appear green. The data shown are representative
of those obtained from at least three mice from each time point.
(B) Representative images of a germinal center at day 5 after transfer. Donor B
cells (2 3 104 injected per recipient mouse) stained with anti-CD45.2 appear
red, GL7-positive cells appear green, and FDC-M2 staining appears blue.
The scale is shown below each column of panels.HKI65-Vk10 B Cells Are Located at the Perimeter
of Follicles during the Early Anti-Ars Response
Splenic B cells enriched from HKI65-Vk10 mice were injected
into immunosufficient, unirradiated, nontransgenic, syngeneic
recipients that had or had not been immunized intraperitoneally
(i.p.) with Ars-keyhole limpet hemocyanin (Ars-KLH) in alum
1week earlier. All recipient mice used in these studies were inca-
pable of expressing canonical BCRs because of absence of the
600 Immunity 30, 599–609, April 17, 2009 ª2009 Elsevier Inc.requisite VH gene segment. This preimmunization approach was
initially taken because we anticipated that it would result in prior
development of a KLH-specific helper T cell compartment suffi-
cient to induce synchronous activation of many Ars-specific
donor B cells. Such an approach would allow effective evalua-
tion of various stages of their subsequent response to antigen
in vivo. In some experiments, donor cells were labeled with
CFSE to allow monitoring of cell division (Lyons and Parish,
1994). Also, in most studies, recipient mice were strain C57BL/
6.CD45.1 (B6.CD45.1) and as such permitted distinction of
donor and host B cells with the CD45.1-CD45.2 allotype system,
irrespective of the structure and expression of their BCRs.
One day after transfer, donor B cells were mainly found by
histological analyses to be scattered throughout follicles in unim-
munized chimeric mice, a distribution that persisted for 10 days.
Flow cytometric analysis at all time points after transfer did not
reveal proliferation or expression of the GC activation marker
GL7 by donor B cells in these mice (data not shown). B cells
transferred to immunized mice were also observed in follicles
on day 1. However, a major subset of these cells was concen-
trated at the interface of follicles and the periarteriolar lymphoid
sheath (PALS) T cell zones (Figure 1A, top row), where initial
cognate interaction of antigen-specific B cells and T cells most
probably takes place (Jacob et al., 1991; Liu et al., 1991; Jacob
andKelsoe, 1992;Martin andGoodnow, 2002; Pape et al., 2003).
By day 2, staining with anti-CD45.2 (Figure 1A) and 5Ci (data
not shown) revealed small numbers of donor B cells located at
the perimeter of follicles, near the border with the marginal
zone (MZ) (defined by staining of metallophillic MZ cells with
the mAb MOMA1). Most donor cells in this locale were distal to
the PALS (Figure 1A, day 2). By day 3, donor B cells were
numerous in this region (Figure 1A, day 3). At day 4, donor B cells
were abundant in the center of follicles (Figure 1A, day 4). By day
5, most of these cells were located in GCs, as defined by staining
with GL7 for GC B cells and FDC-M2 for FDCs (Figure 1B). These
results suggested that canonical HKI65-Vk10 B cells were
undergoing clonal expansion at the perimeter of follicles prior
to entering the GC reaction.
HKI65-Vk10 B Cells Undergo Rapid Proliferation
at the Perimeter of Follicles Prior to Entering GCs
To test this idea, we performed histological studies by using
a mAb specific for the nuclear proliferation antigen Ki67 and
flow cytometric analyses for dilution of CFSE in donor B cells.
Figure 2A (day 1, top row) illustrates that only a small percentage
of donor B cells present in and around the T cell zone at day 1
were Ki67+. In marked contrast, by days 2 and 3, the majority
of these B cells, now located at the perimeter of follicles, were
Ki67+ (Figure 2A, day 2 and day 3). The results of quantification
of such data are presented in Figure 2B. As expected from
previous studies (Camacho et al., 1998; Rahman et al., 2003),
by day 4, nearly all donor B cells, now located in GCs in the
center of follicles, were Ki67+ (Figure 2A, day 4). In addition,
BrdU-pulse-labeling studies showed that anti-clonotype+ B cells
in the S phase were numerous in the locale of the perimeter of
follicles in the day 2 to 4 time frame (data not shown). These
data showed that HKI65-Vk10 B cells are actively proliferating
while they are located at the follicular perimeter.
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Figure 2. Proliferation of HKI65-Vk10 Donor B Cells at the Perimeter
of Follicles in Preimmunized Mice
Chimeric HKI65-Vk10 mice were created and immunized as described in the
legend to Figure 1.
(A) Panels in the left column illustrate the location of donor 5Ci+ B cells (red),
T cells (blue), and MZ metallophiles (green) at different time points during the
course of the Ars-KLH response. Panels in the center column show the result
of staining of adjacent sections for the Ki67 nuclear proliferation antigen (blue),
donor B cells (red), and MZ metallophiles (green). The right column of images
showsmagnified regions of areas delineated by yellow rectangles in the center
panels. The scale is shown in the lower panel of each column. Data were ob-
tained from mice injected with the following numbers of donor B cells: day 1,
107; day 3, 106; days 2 and 4, 2 3 105. The data shown are representative of
those obtained from at least three mice from each time point.
(B) Quantitative analysis of E4+ B cell proliferation at the perimeter of follicles
on the indicated days. Data obtained represent the percentage of canonical
HKI65-Vk10 E4+ B cells that were also Ki67+ counted within 15 cell diameters
from the band of MOMA1+ cells that delineate the MZ-follicle border. Each
circle represents data from an individual field along this border. Data were
obtained from three mice for days 1 and 3 and from two mice for day 2. The
p values were calculated with a two-tailed Student’s t test.Localization and Proliferation of Pre-GC B Cells
at Follicular Perimeters without Preimmunization
Introduction of naive donor B cells into mice with ongoing
immune responses and GC reactions clearly does not directly
mimic conditions at the onset of a conventional immune
response. As such, we conducted an extensive series of studies
in which naive HKI65-Vk10 splenic B cells were injected into
nonirradiated, syngeneic recipients; this was followed by i.p.
immunization of the resulting chimeric mice with Ars-KLH in
alum 12 hr later. Control studies revealed few, if any, GCs in the
spleens of naive recipient mice prior to cell transfer and immuni-
zation (data not shown). Figure 3 illustrates that results entirely
analogous to those obtained with the preimmunization protocol
were obtained with this postimmunization approach, although
donor B cell localization to and proliferation in the follicular perim-
eter and subsequent donor B cell entry into GCswere delayed by
1–2 days as compared to the preimmunization situation, and the
response of these donor cells appeared less synchronous.
WenextcombinedCFSE labelingof donorBcellswithhistolog-
ical and flow cytometry analyses to extend the resolution of these
postimmunization protocol studies. At day 2 after immunization,
donor B cells were predominantly located at the interface of the
follicle and the PALS and had not undergone detectable levels
of proliferation (data not shown). Figure 4A illustrates that at day
3 after immunization, donor B cells were located both at the inter-
face of the follicles and PALS and in the follicular perimeter. Flow
cytometric measurement of CFSE dilution and other markers
revealed that the majority of donor B cell had not undergone
proliferation at this time point (Figure 4C, upper-left panel). By
day 4, however, most donor B cells were located at the follicular
perimeter and many were Ki67+ (Figure 4B). Figure 4B, lower
left, illustrates that all of the donor B cells located in this region
lacked CFSE fluorescence, most probably because of the fact
that active proliferation had diluted their levels of CFSE below
the detection limit of fluorescence microscopy. Flow cytometry
demonstrated that a major fraction of these cells had divided
two to four times (Figure 4C, lower panels). Figure 4C also illus-
trates that while proliferating, donor B cells at days 3 and 4 had
begun to acquire the GL7 activation marker and expressed
progressively lower amounts of surface IgD. They had not yet
become PNA+ and did not express detectable surface IgG.
Analogous results were obtained with the preimmunization
protocol (Figure S1 available online). However, in these studies
nearly all donor B cells were recruited into the proliferative
response, and this response was accelerated by several days.
Also, proliferating donor B cells expressed higher, very uniform
amounts of the GL7 marker, intermediate amounts of PNA
binding, and lower amounts of sIgD than those observed with
the postimmunization protocol. A minor fraction of such cells
also appeared to acquire expression of sIgG. We speculate
that these differences are due to the high degree of antigen-
specific T cell help available to donor B cells as they are incorpo-
rated into an already ongoing immune response.
Some B cells participating in the early stages of certain
TD immune responses are destined for development into plas-
mablasts (Liu et al., 1991; Jacob and Kelsoe, 1992; McHeyzer-
Williams et al., 1993; Smith et al., 1996; Shih et al., 2002; Pape
et al., 2003). Because such cells would not express GL7 and
might only express low amounts of B220 but high amounts ofImmunity 30, 599–609, April 17, 2009 ª2009 Elsevier Inc. 601
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tion of CFSE in B220+, GL7, and B220 andCD138+ donor cells
in the chimeric mice. Cell division was only observed in the
B220high and CD138 subpopulations (Figure S1C, top panels;
data not shown). Moreover, using both protocols, we did not
observe many proliferating donor B cells in the blood during
the time of rapid proliferation in the spleen (Figure S2). Taken
together with the Ki67 staining studies described above, this
argues that most, if not all, of the pre-GC B cell proliferative
response take place at the follicular perimeter. Finally, we also
investigated the influence of canonical B cell precursor
frequency on the results obtained in both protocols. For these
studies, HKI65-Vk10 B cells were injected in various doses. As
few as 23 104 donor B cells could be injected and subsequently
detected via histological analyses (see legend to Figure 1 for
examples). The results obtained with this small number of cells
were analogous to those obtained with larger number of cells.
Canonical B Cells in Ars-KLH Immunized Transgene
Igh+/ Mice Proliferate at the Follicular Perimeter
HKI65 transgene-targeted hemizygous mice (HKI65 Igh+/) have




Figure 3. HKI65-Vk10 B Cell Localization to and
Proliferation at the Follicular Perimeter DoNot Require
Preimmunization
Experiments were performed as described in the legends to
Figures 1 and 2 except that recipient mice were not preimmu-
nized. Instead, chimeric mice were immunized 12 hr after cell
transfer with Ars-KLH in alum i.p. In all experiments illustrated,
105 purified donor HKI65-Vk10 splenic B cells were injected
per recipient.
(A) Adjacent spleen sections obtained at the indicated time
points after immunization were stained with antibodies
specific for the indicated markers. The scales for images in
the right and center columns are indicated in the lower panels
of each respective column. The images in the right column are
magnified regions of areas delineated by the yellow rectangles
in day 4, center panel.
(B) Quantitative analysis of CD45.2+ B cell proliferation at the
perimeter of follicles on the indicated days. Data obtained
represent the percentage of canonical HKI65-Vk10 CD45.2+
B cells that were also Ki67+ counted within 15 cell diameters
from the band of MOMA1+ cells that delineate the MZ-follicle
border. Each circle represents data from an individual field
along this border. Data were obtained from three experiments,
in which three to four mice were sacrificed at each time point.
A p value was determined with a two-tailed Student’s t test.
(C) Spleen sections obtained from chimeric mice 6 days after
immunization were stained with antibodies specific for the
indicated markers. Data obtained from a representative GC
are shown. The scale of the images is indicated in the right
panel.
endogenous L chain genes. Nonetheless, canonical
B cells can be identified in these mice with the anti-
clonotypic E4 mAb. To investigate the possibility
that localization of proliferating canonical B cells
to the follicular perimeter in the studies described
above was influenced by the adoptive transfer
protocols, we directly immunized HKI65 Igh+/
mice with Ars-KLH in alum and performed histological analysis
of the canonical B cell response in the spleen at several time
points.
As expected, the canonical B cell response in this case was far
less uniform and synchronous as compared to that observed
with adoptive transfer protocols. Nonetheless, at day 4 after
immunization, many E4+ B cells were observed at the follicle-
PALS interface, and at day 5 and into day 6, this distribution
had changed dramatically in that a major subpopulation of
canonical B cells were now observed at the follicular perimeter
(Figure S3A). Ki67 staining analysis showed that many of the
donor B cells in this locale were proliferating (Figures S3B and
S3C). These results strongly indicated that proliferation of pre-
GCB cells at the follicular perimeter is not a result of the adoptive
transfer protocol used in our studies.
HKI65-Vk10 B Cells at the Perimeter of Follicles Have
a Unique Developmental Gene Expression Profile
The above studies suggested that canonical B cells at the perim-
eter of follicles in immunized mice were intermediates between
those initially activated at the T-B interface and GC B cells. We
further examined this issue by analyzing the expression of602 Immunity 30, 599–609, April 17, 2009 ª2009 Elsevier Inc.
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and Changes in Cell-Surface Phenotype
during the Response at the Follicular
Perimeter
Chimeric mice were generated and immunized as
described in the legend to Figure 3 with CFSE-
labeled donor B cells. Spleens isolated at the
indicted time points were halved so that one
portion could be analyzed by immunofluores-
cence staining and the other could be analyzed
by flow cytometry. In all illustrated experiments,
3 3 106 donor splenic B cells were injected per
recipient mouse.
(A) Adjacent spleen sections obtained on day 3
after immunization were stained with Abs specific
for the indicated markers and analyzed by immu-
nofluorescence microscopy. The scale for day 3
images is shown in the lower panel.
(B) Images were obtained from adjacent sections
of spleens taken on day 4 stained with the indi-
cated Abs. A scale for the left and top right panel
is shown in the bottom-left panel. The lower-right
panel is a magnified image of the region sur-
rounded by a dashed rectangle in the top-right
panel.
(C) Spleen cells were stained with the indicated
antibodies or reagents and expression levels of
the various markers detected were analyzed by
flow cytometry. Dilution of CFSE fluorescence in
donor cells was not detected until day 3. The
data in this figure are representative of those
obtained in three independent experiments in
which two to three mice were sacrificed on each
day.various genes required for GC and AFC development and B cell
migration viaQ-RT-PCR in four subpopulations of B cells purified
by FACS: naive B cells from C57BL/6 mice (used as a standard)
and three fractions of B cells from chimeric mice at day 3 after
donor cell injection of immunized recipient mice: GL7, CFSE+,
(donor B cells that had not divided), GL7int, CFSEint (donor cells
that had divided four to six times), and GL7+, CFSE cells (donor
and host GC B cells that had divided extensively, see lower-right
inset, Figure 5).
Figures 5A and 5B illustrate that, as predicted from previous
studies, GL7+, CFSE GC B cells expressed high levels of RNA
encoding activation induced cytidine deaminase (AID) (Mura-
matsu et al., 1999), IgG H chain and Bcl-6 (Onizuka et al.,
1995; Cattoretti et al., 1995; Allman et al., 1996; Flenghi et al.,
1996), CXCR4 (Allen et al., 2004), and CXCR5 as compared to
naive B cells. These cells expressed moderate amounts of
BLIMP-1 and nearly undetectable CCR7 RNA. In contrast,
GL7, CFSE+ donor B cells had undetectable RNA encoding
AID, low amounts for IgG H chain, modest amounts for Bcl-6,
BLIMP-1, and CXCR5, very low amounts for CXCR4, and high
levels for CCR7. This expression profile is consistent with B cells
that had recently left the interface of B and T cell zones, given
that CCR7 is required for B cell migration to this locale (Reif
et al., 2002; Cyster, 2005). Cells with a GL7int, CFSEint phenotype
expressed low amounts of RNA for AID and Bcl-6, and very low
to undetectable amounts of RNA for IgG, BLIMP-1, CCR7,
CXCR4, and CXCR5. The low expression of RNA for the chemo-kine receptors indicated that these cells, predominantly located
at the perimeter of follicles, were sessile. Histological analyses
confirmed that few donor B cells in this locale expressed IgG
at the day 3 time point (data not shown). In total, these data
support the conclusion that proliferation of cells at the follicular
perimeter constitutes a discrete stage in memory B cell develop-
ment.
B Cell Proliferation at the Perimeter of Follicles
Is Not Accompanied by Somatic Hypermutation
To further test this idea, we determined whether donor HKI65-
Vk10 B cells that had undergone various numbers of divisions
in the chimeric mice had activated SHM to an extent character-
istic of GC B cells. B cells present in different CFSE intensity
peaks were purified by FACS. The HKI65 VH locus was PCR
amplified from these fractions, and the products were cloned
and sequenced. No mutations were found in VH clones ob-
tained from division peaks zero and five isolated 3 days after
donor cell injection (Table S1). In contrast, anticlonotype+
GCs microdissected from sections of spleens isolated at day
5 after donor cell transfer yielded HKI65 PCR VH clones with
an average mutation frequency of 0.4%, and 30% of these
mutations were found in SHM ‘‘hotspots.’’ These mutations
were rather randomly distributed, and those known to increase
affinity for Ars were rare (data not shown), as would be ex-
pected at this early stage of the GC reaction (Berek et al.,
1991; Jacob et al., 1993; McHeyzer-Williams et al., 1993).Immunity 30, 599–609, April 17, 2009 ª2009 Elsevier Inc. 603
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low and very high amounts of AID expression were apparent
in donor GL7int, CFSEint, and GL7+, CFSE (GC) B cells,
respectively.
Anti-HEL Ig Transgenic B Cells Rapidly Proliferate
at the Perimeter of Follicles
We next considered that the rapid proliferative response of
pre-GC B cells at the perimeter of follicles might only take
place during immune responses to certain antigens. To inves-
tigate this possibility, we injected B cells expressing a trans-
gene-encoded BCR specific for hen egg lysozyme (HEL) into
immunosufficient, nonirradiated, nontransgenic, syngeneic
recipients either primed 3 days earlier with HEL in alum i.p.
or 12 hr after cell transfer. Results analogous to those ob-
tained with the HKI65/Ars system were found in this study
(Figure 6). Specifically, at days 2 and 3 of the response in
the preimmunization protocol (Figure 6A, left and center
panels) and day 6 of the postimmunization protocol
(Figure 6B, right panels), the majority of donor (IgMa+) B cells
and were located at the perimeter of follicles. By day 4 of
the preimmunization protocol and day 7 of the postimmuniza-
tion protocol, many of these donor B cells were becoming
GL7+ and had entered or formed GCs (Figure 6A, lower-right
panel and Figure 6B, day 7). Detailed staining analysis of the
GCs obtained with the postimmunization protocol showed
that they contained a low frequency of CD4+ T cells (Figure 6B,
day 7) and extensive FDC networks (Figure 6B, right, bottom
panels). Flow cytometric studies using CFSE-labeled anti-
HEL B cells revealed that at the time points at which such cells
Figure 5. Gene Expression Profile of HKI65-
Vk10 Donor B Cells after Different Numbers
of Cell Divisions during the Follicular
Perimeter Response
Ars-KLH-primed recipient mice were injected
with CFSE-labeled splenocytes from HKI65-Vk10
mice (as described in the legend to Figure 1 and
Experimental Procedures) and sacrificed on day
3 after transfer. Spleen cells from the chimeric
mice were stained with anti-B220 and GL7 Abs,
and B cells in different CFSE dilution subpopula-
tions were isolated by FACS (see plot on lower
right). QRT-PCR analyses were performed on
RNA extracted from B220+GL7int, CFSEint cells in
division peak 5 (blue), B220+GL7, CFSE+ cells
in division peak 0 (green), and B220+GL7+, CFSE
cells, representing germinal center B cells (red).
RNA isolated from B cells of naive C57BL/6 mice
(black) served as a reference control whose
QRT-PCR value for each assay was arbitrarily set
to one. All data are representative of at least two
independent experiments. Bar graphs show the
mean values (±SD) of triplicate measurements.
were mainly located at the follicular
perimeter, they had divided several times
and were GL7+ (data not shown). There-
fore, anti-HEL Ig transgenic B cells, like
HKI65-Vk10 transgenic B cells, undergo
rapid proliferation at the follicular perimeter prior to entering the
GC reaction.
Location of Accessory Cells during Pre-GC B Cell
Proliferation at the Follicular Perimeter
CD4+ T cells, FDCs, and certain subclasses of other dendritic
cells (DCs) have all been shown to provide growth, survival,
and differentiation signals to antigen-activated B cells (Clark
and Lane, 1991; Berney et al., 1999; Tew et al., 2001; Ma-
cLennan et al., 2003; Haynes, 2008). To determine whether any
of these cell types were colocalized at the follicular perimeter
during the height of the pre-GC B cell proliferative response
there, we performed more extensive histological analyses by
using the postimmunization protocol. CD11c+ interdigitating
DCs were clearly absent from the follicular perimeter
(Figure 7A, left panels). Sparsely scattered T cells (Figure 7A,
right panels) and FDCs (Figure 7B) were found in this locale,
but they did not appear to be directly associatedwithmost donor
B cells. Also, staining for the MZ B cell marker CD1d (Figure 7C)
suggested that donor B cells had not acquired this phenotype.
Analogous results were obtained with the preimmunization
protocol (data not shown). These data revealed a scarcity of
conventional accessory cells for follicular B cell differentiation
and proliferation at the follicular perimeter.
DISCUSSION
The data presented here demonstrate that during the initial
phases of GC B cell development, rapid proliferation takes place
at the perimeter of follicles. Antigen-activatedBcells in this locale
604 Immunity 30, 599–609, April 17, 2009 ª2009 Elsevier Inc.
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consistent with recent departure from the T cell zone (i.e.,
moderate CCR7 expression prior to proliferation) and ongoing
development via the GC pathway (i.e., low to moderate AID,
BCL-6, and GL7 expression and sIgD downregulation). More-
over, highly proliferative B cells in this locale express very low
levels of RNA encoding CXCR4, CXCR5, and CCR7, indicating
that they are not simply ‘‘in transit’’ from the T cell zone to the
GC. The subsequent migration of large numbers these B cells
to the center of the follicle in which they are resident suggests
that GCs are initially formed by B cell coalescence, rather than
proliferation in situ.
Our results support previous speculations (Jacob et al., 1993;
McHeyzer-Williams et al., 1993) that SHM is not induced during
the initial stages of GC B cell proliferation. Past studies on this
issue were hampered by lack of knowledge of the time in which
GC precursors entered the GC reaction and the degree to which
theseprecursor clones hadexpandingprior to entry.More impor-
tantly, our data indicate that the majority of the ‘‘mutation-free’’
period of pre-GC B cell proliferation takes place at the perimeter
of follicles. Very shortly after entering GCs, however, donor B
cells in our experiments must have substantially upregulated
SHM, given that the majority of the transgenic VH clones we iso-
lated from microdissected GCs 5 days after cell transfer con-
A
B C
Figure 6. Proliferation and Locale of Anti-HEL Trans-
genic B Cells during the Immune Response to HEL
(A) Tg(IghelMD4)4Ccg/J splenocytes (106 per recipient
mouse) were adoptively transferred into nonirradiated
C57BL/6 mice primed 3 days earlier with 100 mg of HEL in
alum and immediately boosted with 50 mg soluble HEL i.p.
On days 2, 3, and 4 after adoptive transfer, donor cell locale
was analyzed by immunohistology with Abs specific for the
indicatedmarkers. Day 4 images were obtained from adjacent
sections. The image scale for all panels is indicated in the
lower-right panel. At days 2 and 3 after transfer, donor B cells
(red) were seen at the perimeter of follicles and at day 4 they
also were detected in GCs. Small GL7+ nascent GCs (green,
day 4, lower panel) were detected in some follicles at day 4.
The data shown are representative of those obtained from at
least two mice at each time point.
(B) Studies analogous to those described for part (A) were
performed, but the postimmunization protocol was used. In
these experiments, 106 donor spleen cells were injected into
each recipient mouse. For day 6 and day 7, the lower panels
show IgMa single-color images of the respective upper panels.
A scale of the images is indicated in the lower panels.
(C) Panels illustrate donor B cells located within GCs (yellow
fluorescence resulting from overlap of IgMa and GL7 staining)
on day 7. Scales for each column of panels are indicated in the
bottom panels. The data are representative of images
acquired from three separate experiments, in which three to
four mice were sacrificed on each day.
tained substantial numbers of somatic mutations.
These data are incompatible with the idea that
high-rateSHMoccurs asa functionofGCBcell divi-
sion alone. In contrast, they support the notion that
a B cell-extrinsic factor(s) present in the GC proper
is required to promote this process.
Our results demonstrating very low or undetect-
able heavy-chain class switching in B cells rapidly
proliferating at the perimeter of follicles contrast with past find-
ings also obtained with a transgenic B cell adoptive transfer
approach. In these studies, a major fraction of donor B cells
were found to have switched to IgG expression at the T-B inter-
face and in the follicles of the spleen 4 days after immunization
and to have undergone more extensive expansion than their
IgM-expressing counterparts (Pape et al., 2003). Another
previous study suggested that the cytoplasmic tail of membrane
IgG confers a proliferative advantage to responding B cells in the
AFC pathway (Martin and Goodnow, 2002). Nonetheless, our
data demonstrate that expression of an IgG form of the BCR is
not a prerequisite for the dramatic burst of proliferation charac-
teristic of the early stages of pre-GC B cell development.
These considerations emphasize the importance of future
studies to determine how changes in themany conditions known
to affect the quantity and quality of B cell responses impinge
upon proliferation and differentiation at the perimeter of follicles.
For example, the response of most anti-HEL B cells in this locale
was characterized by both rapid proliferation and induction of
GL7 and PNA binding, both classical GC B cell markers. In
contrast, the proliferative response of HKI65-Vk10 B cells in
this locale was slower and accompanied by a more gradual
induction of GL7, as well as reduction of IgD expression. It is
tempting to speculate that variation in the affinity of the BCR(s)
Immunity 30, 599–609, April 17, 2009 ª2009 Elsevier Inc. 605
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The Site of Pre-GC B Cell Proliferationexpressed by donor B cells for the driving antigen resulted in the
differences in cellular behavior described here (e.g., the Ka of the
HKI65-Vk10 BCR for Ars is 2 3 105 (Rothstein et al., 1983),
whereas the Ka of the anti-HEL BCR for HEL is >10
8 (Goodnow
et al., 1988) and in previous studies.
In total, our results demonstrate that a previously unrecog-
nized microenvironment existing at the perimeter of follicles
opposite the T cell zone can promote the initial proliferative
stages of the GC B cell response, namely, after primary interac-
tion with T cells at the interface of follicles and the T cell zone,
and prior to formation of or entry into the GC. Although our
studies were restricted to the spleen, others have observed
antigen-specific B cell proliferation in the subcapsular perimeter
of lymph node follicles after immunization with a TD antigen
(Garside et al., 1998) and have described a unique class of
antigen-transporting DCs that localize to this region of LNs
shortly after immunization (Berney et al., 1999). Future studies
on the factors that regulate the migration of recently activated
B cells to and retention and activity of pre-GC B cells in this
microenvironment are clearly required.
What might be the function of this intermediate stage of rapid
clonal expansion during TD B cell responses in which the struc-
ture and function of BCRs remain largely unaltered? In the
context of natural infections, Cohn noted many years ago
(Cohn, 1972) that unless a large pool of pathogen-specific
lymphocytes was generated in a short period of time, the infec-
A
B C
Figure 7. Location of Accessory Cells during the
HKI65-Vk10 B Cell Proliferative Response at the
Follicular Perimeter
Chimeric mice immunized with Ars-KLH in alum 12 hr after
donor cell transfer were sacrificed on day 4 of the response,
and spleens were analyzed by immunohistology with Abs
specific for the indicated markers. In all experiments, 105 puri-
fied donor splenic B cells were injected per recipient mouse.
(A) Location of donor B cells, T cells, and CD11c+ DCs. The
center column shows single CD45.2 staining from multicolor
images acquired for the respective panels in the left column.
The scale for all images is indicated in the upper-right panel.
(B) Location of donor B cells and FDCs. Examples of data from
two sets of adjacent sections are shown. The image scale is
indicated in the lower-right panel.
(C) Location of donor B cells and CD1d+ (mainly MZ) B cells.
Data from two sections are illustrated as in (B). Notice the
lack of overlap of CD1d (blue) staining and donor (CD45.2,
red) staining. The image scale is indicated in the lower-right
panel.
tion would overwhelm the host as a result of the
high replicative capacity of most pathogens. Since
that time, numerous studies have shown that the
GC reaction is an extremely dynamic process in
which BCR structures are modified by SHM and
CSR, and stringent selective forces are brought to
bear on GC B cells on the basis of the affinity and
specificity of their BCRs (Kelsoe and Zheng,
1993; MacLennan, 1994; Liu and Arpin, 1997;
Camacho et al., 1998). SHM alters the structure of
antibody V regions rather randomly (Winter and
Gearhart, 1998), and for this reason the majority
of somatic mutations are expected to disrupt expression of
BCRs, or alter their affinity and specificity such that the GC B
cells expressing them are counter selected (Shlomchik et al.,
1989; Casson and Manser, 1995; Wiens et al., 1998). Given
such considerations, the average rate of SHM per GC B cell
division has been argued to approach that which would prevent
the clonal expansion of B cells during an immune response
(Shlomchik et al., 1989). This suggests that if individual GCs
are founded by only small numbers of B cell precursors, subse-
quent generation of effector populations of sufficient size,
expressing BCRs of the affinity and specificity necessary for
rapid antigen (pathogen) clearance, might not occur. Therefore,
proliferation of pre-GC B cells at the perimeter of the follicle may
allow nucleation of the GC reaction by antigen-specific clones
large enough to ensure a productive outcome of the subsequent
GC response. This scenario would not be inconsistent with the
fact that the GC reaction is oligoclonal (Kroese et al., 1987;
Jacob et al., 1991; Liu et al., 1991) if the number of B cell precur-
sors to the proliferative phase of the response at the follicular
perimeter was limited or if affinity and specificity-based clonal
selection took place in this microenvironment.
Limited CSR during this phase of the response may serve
a similar function. As discussed above, IgG forms of the BCR
appear to have enhanced ability to stimulate proliferation as
compared to IgM and IgD forms (Martin and Goodnow, 2002;
Pape et al., 2003). Therefore, CSR to IgG isotypes could interfere
606 Immunity 30, 599–609, April 17, 2009 ª2009 Elsevier Inc.
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and that are specific for the driving antigen as a result of SHM.
Moreover, delaying the irreversible decision regarding which of
the H chain isotypes to express as secreted antibody until
after the mutation-selection process is well underway may maxi-
mize the probability that highly specific antibodies with effector
functions most suited to the nature of the infecting pathogen
are generated during TD immune responses. Testing these ideas
will require the development of experimental approaches that
selectively perturb the migration to and proliferation of B cells
at the perimeter of follicles. In this regard, chemokine receptors
expressed by responding B cells seem particularly obvious
targets. Indeed, Cyster and colleagues (Reif et al., 2002) have
observed lodging of CCR7-deficient anti-HEL transgenic B cells
at the follicular perimeter after transfer into HEL immunized,
CCR7-sufficient recipient mice.
In total, the data we present reveal a previously unappreciated
stage of memory B cell development in which rapid clonal
expansion takes place in the absence of differentiation at the
perimeter of follicles. We suggest that this proliferative phase
provides a precursor population for the GC reaction of sufficient
size to ensure the subsequent development of thememory B cell
compartment. These findings necessitate revision of current
models of the TD B cell immune response.
EXPERIMENTAL PROCEDURES
Mice
HKI65 VH mice have been previously described (Heltemes-Harris et al., 2004).
To produce the double-transgenic HKI65-Vk10 mouse line, we bred HKI65
mice to a line of conventional Vk10A light-chain transgenic mice termed
Vk1060 (a kind gift of L. Wysocki). Vk1060 transgenic mice bear a functional
Vk10A-Jk1 gene encoding the light chain of canonical Ars antibodies. Tg(Igh-
elMD4)4Ccg/J mice were purchased from the Jackson Laboratory (Bar
Harbor, ME, USA). C57BL/6 and B6.SJL-Ptprca Pepcb/BoyJ (B6.CD45.1)
mice were originally obtained from the Jackson Laboratory and were bred in
house. Mice were housed under pathogen-free conditions and were given
autoclaved food and water. The use of mice in these studies was approved
by the university’s institutional animal care and use committee.
Adoptive Transfers and Immunizations
B cells were enriched from HKI65-Vk10 or Tg(IghelMD4)4Ccg/J spleens via
anti-CD4, anti-CD8 and anti-Thy1.2 and C-mediated lysis. Alternatively, non-
B cells were depleted by incubation with biotinylated anti-CD3, anti-Thy1.2
and anti-CD11b (Mac-1), or anti-CD43 followed by MACS (Milteny Biotec,
Auburn, CA, USA). In some experiments, enriched B cells were labeled with
CFSE (Molecular Probes, Eugene, OR, USA) as previously described (Lyons
and Parish, 1994). B cells (2 3 104 to 2 3 107) were injected into the tail vein
or retro-orbital sinus of syngeneic recipients. Three immunization protocols
were used. Recipientmicewere either injectedwith donor cells and immunized
12 hr later with 100 mg of Ars-KLH (or HEL) in alum i.p. (postimmunization
protocol) or received 100 mg of Ars-KLH (or HEL) in alum i.p. 1 week or
3 days before cell transfer with an additional injection of 50 mg of Ars-KLH
(or HEL) in PBS i.p. at the time of adoptive transfer (preimmunization
protocols).
Immunofluorescence
Spleens were snap frozen in OCT compound and cryosections (5–6 mm) made
as previously described (Vora et al., 1998). Immunofluorescence staining was
also performed as previously described (Heltemes-Harris et al., 2004). The
following mAbs and reagents were used: E4-biotin, 5Ci-biotin (both made in
house), anti-CD1d-biotin, and anti-TCRb (H57-597)-biotin (both from BD
Biosciences) and then SA-PE (Molecular Probes) or SA-Alexa 633 (Molecular
Probes); rat anti-CD169 (MOMA1) (Serotec, Raleigh, NC, USA), rat anti-mouseKi67 (DakoCytomation, Glostrup, Denmark), FDC-M1, and FDC-M2 (both from
ImmunoKontact, Abingdon, UK) and then goat anti-rat IgG-Alexa 633 (Molec-
ular Probes); GL7-FITC, MOMA1-FITC (Serotec); anti-CD11c-FITC; anti-B220
(RA3-6B2)-FITC, anti-TCRb (H57-597)-PE and FITC, anti-IgMa-PE, and anti-
CD35-PE (all from BD Biosciences); and anti-CD45.2 (104)-PE (eBioscience).
5-Bromo-20-Deoxyuridine Labeling and Analysis
5-bromo-20-deoxyuridine (BrdU) labeling was performed with the BrdU
Labeling and Detection Kit II from Roche Diagnostics Corporation (Indianapo-
lis, IN, USA) and BrdU (Sigma-Aldrich, St. Louis, MO, USA). In brief, mice were
injected i.p. with 1 mg of BrdU and sacrificed 5 or 12 hr later. Spleens were
snap frozen in OCT compound and cryosections (5–6 mm) made as previously
described (Vora et al., 1998). BrdU detection was done as described in the kit
manual. Alternatively, BrdU-labeled cells were revealed with rat BrdU anti-
bodies (Serotec) and then mouse anti-rat IgG-AP (Jackson Immunoresearch
Laboratories).
Flow Cytometry
Single-cell suspensions were prepared and stained with combinations of the
following Abs and reagents: E4-biotin (made in house), PNA-biotin (Vector
Laboratories), GL7, anti-B220 (RA3-6B2)-PE, anti-CD45.2 (104)-PE, anti-
CD138 (281.2)-PE (all from BD Biosciences), anti-CD45.2-PE and biotin
(eBiosciences), anti-IgD (11-26)-PE (Southern Biotech, Birmingham, AL), and
anti-mouse IgG-biotin (Jackson Immunoresearch). Staining with GL7 was
followed by staining with biotin-mouse anti-rat IgG (Jackson Immunoresearch
Laboratories). Whole-mouse Ig (Jackson Immunoresearch Laboratories) was
used for blocking Fc receptors. CyChrome-SA (BD Biosciences), SA-PerCP-
Cy5.5, or SA-PE-Cy5.5 (both from eBioscience) were used for detecting
biotinylated Abs and other reagents.
Cells were either sorted immediately with an EPICS Elite-ESP or a MoFlo
high-performance cell sorter (DakoCytomation) or analyzed on an EPICS
XL-MCL (Coulter, Hialeah, FL, USA). If not analyzed immediately, cells were
fixed in 2% formaldehyde. Data were analyzed with the FLOWJO software
(Treestar, San Carlos, CA, USA).
Molecular Genetics
B cells in peaks of CFSE fluorescence intensity corresponding to different cell
divisions were sorted into 13 PBS. Genomic DNA was isolated with the
DNeasy Blood & Tissue Kit (QIAGEN). For laser capture microdissection of
GCs, frozen spleen sections (7–8 mm)weremounted on PEN-Membrane slides
(Leica) and immunohistochemistry was performed as previously described
(Vora et al., 1998). In brief, sections were labeled sequentially with anti-
CD45.2 (104)-biotin (eBioscience), SA-AP (Vector), and PNA-HRP (Sigma).
Slides were developed with the Alkaline Phosphatase Substrate Kit III and No-
vaRed Substrate kit for peroxidase (both from Vector). Tissue from individual
PNA+, CD45.2+ GCs was microdissected with the LMD6000 laser microdis-
section system (Leica), and genomic DNA was released by Proteinase K treat-
ment. The HKI65 VH locus was amplified via nested PCR performed on DNA
from sorted cells and microdissected tissue samples with Pfx50 DNA poly-
merase (Invitrogen). A first round of 35 cycles was performed with the primers
50-CAACCTATGATCAGTGTCCTC-30 (hybridizing 50 of the leader exon) and
50-GGACTCCACCAACACCATCAC-30 (hybridizing to the JH2-JH3 intron).
A small aliquot of the first round was amplified an additional 32 cycles with
the primers 50-CAGGTGTCCACTCTGAGGTTC-30 (hybridizing to the end of
the leader exon and the beginning of the HKI65 VH locus) and 5
0-GTGTCCCTA
GTCCTTCATGACC-30 (hybridizing to the JH2-JH3 intron 50 to the first-round
reverse primer). PCR products of the expected size were cloned into plasmid
vectors, sequenced at the Kimmel Cancer Center Nucleic Acids Facility and
analyzed with CLUSTALW multiple sequence alignment program.
RNA from sorted cells was extracted with the RNeasy mini kit (QIAGEN),
according to the manufacturer’s instructions and first-strand cDNA was
synthesized with TaqMan reverse transcription reagents (Applied Biosystems,
Foster City, CA, USA). Quantitative real-time RT-PCR was performed with the
following gene expression assays: Mm 99999055_m1 (Cxcr4), Mm00432086
(Blr1), Mm01301785_m1 (Ccr7), Mm00507774_m1 (Aicda), Mm01703609_g1
(Ighg), Mm00477633_m1 (Bcl6), Mm00476128 (Prdm1), Mm99999915_g1
(Gapdh), and universal master mix (Applied Biosystems). Data were collectedImmunity 30, 599–609, April 17, 2009 ª2009 Elsevier Inc. 607
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Individual gene expression was normalized to GAPDH.
Statistical Analysis
Statistical significance was determined with two-tailed, unpaired Student’s t
test in the Microsoft Excel program.
SUPPLEMENTAL DATA
Supplemental Data include three figures and one table and can be found
with this article online at http://www.immunity.com/supplemental/S1074-
7613(09)00116-2.
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